Lars Robert Boesgaard

Lars Robert Boesgaard currently works at Lindhardt og Ringhof Forlag A, as Chief Executive Officer from 2011, Danske Forlag, as Deputy Chairman, Clio ApS, as Chairman, Cappelen Damm Holding AS, as Director from 2014, and PDS Biotechnology Corp., as Chief Financial Officer from 2023.
Mr. Boesgaard also formerly worked at Alexion Pharmaceuticals, Inc., as Senior Director-Financial Services from 2004 to 2007, ACNielsen Corp., as Finance Director from 2000 to 2004, Novo Nordisk A, as Manager-Accounts Receivable, Insulet Corp., as Vice President-Finance, The Cannabist Company Holdings, Inc., as Chief Financial Officer from 2019 to 2021, Sorrento Tech, Inc., as Chief Financial Officer, Treasurer & VP from 2015 to 2018, and AM-Pharma BV, as Chief Financial Officer from 2021 to 2023.
Mr. Boesgaard received his undergraduate degree from Copenhagen Business School and Masters Business Admin degree from Richard Ivey School of Business.